PharmGKB summary: very important pharmacogene information for ABCG2.
作者信息
Fohner Alison E, Brackman Deanna J, Giacomini Kathleen M, Altman Russ B, Klein Teri E
机构信息
Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
出版信息
Pharmacogenet Genomics. 2017 Nov;27(11):420-427. doi: 10.1097/FPC.0000000000000305.
Abstract
摘要
相似文献
1
PharmGKB summary: very important pharmacogene information for ABCG2.药物基因组知识库总结：ABCG2的非常重要的药物基因信息。
Pharmacogenet Genomics. 2017 Nov;27(11):420-427. doi: 10.1097/FPC.0000000000000305.
2
A Combined Bioinformatic and Nanoparticle-Based Study Reveal the Role of ABCG2 in the Drug Resistant Breast Cancer.一项联合生物信息学和基于纳米粒子的研究揭示了 ABCG2 在耐药性乳腺癌中的作用。
Recent Pat Anticancer Drug Discov. 2021;16(3):393-406. doi: 10.2174/1574892816666210218220531.
3
Residues contributing to drug transport by ABCG2 are localised to multiple drug-binding pockets.与 ABCG2 介导的药物转运相关的残基定位于多个药物结合口袋中。
Biochem J. 2018 May 4;475(9):1553-1567. doi: 10.1042/BCJ20170923.
4
The ABCG2/BCRP transporter and its variants - from structure to pathology.ABCG2/BCRP 转运体及其变体 - 从结构到病理学。
FEBS Lett. 2020 Dec;594(23):4012-4034. doi: 10.1002/1873-3468.13947. Epub 2020 Oct 16.
5
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2.家族性早发性高尿酸血症和痛风与新发现的尿酸转运蛋白ABCG2功能异常变异相关。
Arthritis Res Ther. 2019 Oct 28;21(1):219. doi: 10.1186/s13075-019-2007-7.
6
Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression.通过与红细胞膜蛋白表达相关的遗传分析揭示 ABCG2 转运体中的临床相关突变。
Sci Rep. 2018 May 10;8(1):7487. doi: 10.1038/s41598-018-25695-z.
7
Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter.人类 ABCG2 多药转运蛋白天然变异体的细胞表达和功能。
Cell Mol Life Sci. 2020 Jan;77(2):365-378. doi: 10.1007/s00018-019-03186-2. Epub 2019 Jun 28.
8
Polymorphisms of ABCG2 and its impact on clinical relevance.ABCG2 多态性及其对临床相关性的影响。
Biochem Biophys Res Commun. 2018 Sep 5;503(2):408-413. doi: 10.1016/j.bbrc.2018.06.157. Epub 2018 Jul 6.
9
Theoretical insight into the multiple interactions of quinazoline inhibitors with breast cancer resistance protein (BCRP/ABCG2).深入探讨喹唑啉类抑制剂与乳腺癌耐药蛋白（BCRP/ABCG2）的多种相互作用。
J Biomol Struct Dyn. 2020 Sep;38(14):4336-4343. doi: 10.1080/07391102.2019.1677503. Epub 2019 Oct 21.
10
The transport pathway in the ABCG2 protein and its regulation revealed by molecular dynamics simulations.ABCG2 蛋白的转运途径及其分子动力学模拟揭示的调控机制。
Cell Mol Life Sci. 2021 Mar;78(5):2329-2339. doi: 10.1007/s00018-020-03651-3. Epub 2020 Sep 26.
引用本文的文献
1
Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2).乳腺癌耐药蛋白（BCRP/ABCG2）潜在生物标志物的鉴定与临床评估
Clin Pharmacol Ther. 2025 Jul;118(1):177-189. doi: 10.1002/cpt.3657. Epub 2025 Apr 1.
2
Transporters and drug secretion into human breast milk.转运蛋白与药物向人母乳中的分泌。
Expert Opin Drug Metab Toxicol. 2025 Apr;21(4):409-428. doi: 10.1080/17425255.2025.2461479. Epub 2025 Feb 7.
3
Influence of CYP2C8*3 and ABCG2 C421A genetic polymorphisms on trough concentration and molecular response of imatinib in Egyptian patients with chronic myeloid leukemia.CYP2C8*3和ABCG2 C421A基因多态性对埃及慢性髓性白血病患者伊马替尼谷浓度及分子反应的影响
Cancer Chemother Pharmacol. 2024 Dec 23;95(1):12. doi: 10.1007/s00280-024-04723-y.
4
Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy.携带尿苷二磷酸葡萄糖醛酸转移酶多态性 UGT2B7-161C>T(rs7668258)或 UGT1A4*3 c.142T>G(rs2011425)变异等位基因不会对癫痫成人的拉莫三嗪谷浓度产生相关影响。
Eur J Clin Pharmacol. 2023 Aug;79(8):1117-1129. doi: 10.1007/s00228-023-03526-z. Epub 2023 Jun 20.
5
Case report: Hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023?病例报告：甲氨蝶呤引起的一名儿科患者的肝毒性和肾毒性，精准医学在2023年的作用是什么？
Front Pharmacol. 2023 May 2;14:1130548. doi: 10.3389/fphar.2023.1130548. eCollection 2023.
6
Drug metabolism and drug transport of the 100 most prescribed oral drugs.100 种最常开出的口服药物的药物代谢和药物转运。
Basic Clin Pharmacol Toxicol. 2022 Nov;131(5):311-324. doi: 10.1111/bcpt.13780. Epub 2022 Aug 24.
7
Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病幸存者治疗相关心血管并发症的遗传因素。
Pharmacogenomics. 2021 Sep;22(14):885-901. doi: 10.2217/pgs-2021-0067. Epub 2021 Sep 10.
8
ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure.ABCB1和ABCG2共同限制ABCB1/ABCG2底物向人类视网膜的分布，并且单核苷酸多态性Q141K（c.421C>A）可能导致药物暴露增加。
Front Pharmacol. 2021 Jun 16;12:698966. doi: 10.3389/fphar.2021.698966. eCollection 2021.
9
Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics.健康志愿者中别嘌醇的药代动力学和药效学：BCRP Q141K 多态性和患者特征的影响。
Clin Transl Sci. 2021 Jul;14(4):1431-1443. doi: 10.1111/cts.12992. Epub 2021 May 1.
10
ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine.ABC 转运蛋白超家族。最新综述，在癌症多药耐药中的相关性以及与个性化医学的展望。
Mol Biol Rep. 2021 Feb;48(2):1883-1901. doi: 10.1007/s11033-021-06155-w. Epub 2021 Feb 22.
本文引用的文献
1
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma.舒尼替尼在日本肾细胞癌患者中早期血液毒性的特征。
BMC Cancer. 2017 Mar 23;17(1):214. doi: 10.1186/s12885-017-3205-9.
2
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.临床药物遗传学实施联盟（CPIC）指南：CYP2D6 基因型与昂丹司琼和托烷司琼的应用。
Clin Pharmacol Ther. 2017 Aug;102(2):213-218. doi: 10.1002/cpt.598. Epub 2017 Apr 6.
3
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.临床药物遗传学实施联盟（CPIC） CYP2C19 和伏立康唑治疗指南。
Clin Pharmacol Ther. 2017 Jul;102(1):45-51. doi: 10.1002/cpt.583. Epub 2017 Apr 18.
4
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
5
Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction.ABCG2基因功能性变异与舒尼替尼诱导的严重药物不良反应的关联研究
PLoS One. 2016 Feb 25;11(2):e0148177. doi: 10.1371/journal.pone.0148177. eCollection 2016.
6
Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate.高尿酸血症：尿酸转运体 ABCG2 和尿酸的肾部分清除率的作用。
Ann Rheum Dis. 2016 Jul;75(7):1363-6. doi: 10.1136/annrheumdis-2015-208111. Epub 2015 Dec 1.
7
ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.ABCG2功能缺失多态性预示痛风患者对别嘌醇反应不佳。
Pharmacogenomics J. 2017 Mar;17(2):201-203. doi: 10.1038/tpj.2015.101. Epub 2016 Jan 26.
8
New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies.克服ABCG2/BCRP介导的癌症治疗耐药性的新趋势。
J Exp Clin Cancer Res. 2015 Dec 30;34:159. doi: 10.1186/s13046-015-0275-x.
9
A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk.ABCG2基因Q141K和Q126X变异与痛风风险之间关联的荟萃分析。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):9812-23. eCollection 2015.
10
Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation.人乳腺癌耐药蛋白（BCRP/ABCG2）向内构象的三维结构。
Acta Crystallogr D Biol Crystallogr. 2015 Aug;71(Pt 8):1725-35. doi: 10.1107/S1399004715010676. Epub 2015 Jul 31.
Zotero 插件